[Isoptin in the therapy of supraventricular arrhythmia in patients with diabetes mellitus, non-insulin dependent, concurrent with ischemic heart disease].
The article focuses on the action of isoptin as a monotherapy and in the complex with mildronat in 67 patients with non-insulindependent diabetes mellitus (NIDM) and supraventricular arrhythmia. Isoptin has been shown to be a very effective drug in patients with atrial disorders of cardiac rhythm suffering from diabetes mellitus and ischemic heart disease, especially so in a complex therapy with mildronat. The results obtained permit recommending isoptin as an antiarrhythmic drug in NIDM patients.